Manuel Sánchez Cánovas

599 total citations
18 papers, 157 citations indexed

About

Manuel Sánchez Cánovas is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Manuel Sánchez Cánovas has authored 18 papers receiving a total of 157 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 5 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Manuel Sánchez Cánovas's work include Colorectal Cancer Treatments and Studies (4 papers), Advanced Breast Cancer Therapies (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Manuel Sánchez Cánovas is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Advanced Breast Cancer Therapies (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Manuel Sánchez Cánovas collaborates with scholars based in Spain, United States and France. Manuel Sánchez Cánovas's co-authors include Francisco Ayala, Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Aitziber Buqué, Jitka Fučíková, Melody Smith, Elena García-Martínez, Guido Kroemer, Lorenzo Galluzzi and Eva Martínez de Castro and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

In The Last Decade

Manuel Sánchez Cánovas

13 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Sánchez Cánovas Spain 6 103 33 28 27 21 18 157
Nicolas Cloarec France 7 86 0.8× 18 0.5× 31 1.1× 31 1.1× 27 1.3× 18 149
Adam Zayac United States 8 101 1.0× 38 1.2× 38 1.4× 5 0.2× 14 0.7× 21 219
Yana Novis Brazil 6 78 0.8× 8 0.2× 27 1.0× 8 0.3× 28 1.3× 13 171
Priya Sriskandarajah United Kingdom 8 45 0.4× 13 0.4× 27 1.0× 10 0.4× 14 0.7× 19 156
Syed A. Abutalib United States 5 29 0.3× 15 0.5× 19 0.7× 16 0.6× 67 3.2× 11 165
Roald Lindås Norway 9 30 0.3× 73 2.2× 22 0.8× 19 0.7× 46 2.2× 13 230
Ajay Sharma United States 7 61 0.6× 14 0.4× 35 1.3× 12 0.4× 9 0.4× 12 235
J J Viala France 7 34 0.3× 16 0.5× 12 0.4× 10 0.4× 20 1.0× 18 151
Bao‐Wen Tian China 8 107 1.0× 32 1.0× 45 1.6× 49 1.8× 3 0.1× 23 212
Sandra Rutzner Germany 9 108 1.0× 33 1.0× 45 1.6× 24 0.9× 16 161

Countries citing papers authored by Manuel Sánchez Cánovas

Since Specialization
Citations

This map shows the geographic impact of Manuel Sánchez Cánovas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Sánchez Cánovas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Sánchez Cánovas more than expected).

Fields of papers citing papers by Manuel Sánchez Cánovas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Sánchez Cánovas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Sánchez Cánovas. The network helps show where Manuel Sánchez Cánovas may publish in the future.

Co-authorship network of co-authors of Manuel Sánchez Cánovas

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Sánchez Cánovas. A scholar is included among the top collaborators of Manuel Sánchez Cánovas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Sánchez Cánovas. Manuel Sánchez Cánovas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cánovas, Manuel Sánchez, et al.. (2025). Hospital at home for oncologic patients: SEOM–SEHAD consensus on clinical practice. Clinical & Translational Oncology. 27(10). 3860–3866.
2.
Adoamnei, Evdochia, et al.. (2023). 2145P Thromboembolic disease associated with cyclin-dependent kinase inhibitors in patients with breast cancer. Annals of Oncology. 34. S1117–S1117. 1 indexed citations
3.
Cánovas, Manuel Sánchez, et al.. (2023). Upper digestive bleeding secondary to duodenal infiltration due to pancreatic cancer: a therapeutic challenge. Revista Española de Enfermedades Digestivas. 115(6). 346–346.
4.
Morán, L. Ortega, Manuel Sánchez Cánovas, Mercedes Salgado Fernández, et al.. (2022). P-11 Venous thromboembolism in colorectal cancer patients with BRAF mutation. Annals of Oncology. 33. S249–S250.
5.
Cánovas, Manuel Sánchez, et al.. (2022). Immune-mediated colitis secondary to treatment with nivolumab-ipilimumab in a patient with stage IV kidney cancer: what to do when corticosteroids fail?. Revista Española de Enfermedades Digestivas. 114(9). 554–555.
6.
Montés, Ana Fernández, Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, et al.. (2021). Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data. Scientific Reports. 11(1). 14321–14321. 5 indexed citations
7.
Pacheco-Barcía, Vilma, Berta Obispo, David Páez, et al.. (2021). 1847P Professional standing of young medical oncologists in Spain during COVID-19 pandemic: A nationwide survey by the Spanish Society of Medical Oncology (SEOM) +MIR Section. Annals of Oncology. 32. S1245–S1246. 1 indexed citations
8.
Pérez-Garcı́a, Victor M., et al.. (2021). 317P Survival analysis and prognostic factors in patients with metastatic breast cancer and oligometastatic disease. Annals of Oncology. 32. S503–S503.
9.
10.
Cánovas, Manuel Sánchez, et al.. (2020). SEVERE GASTROINTESTINAL TOXICITY SECONDARY TO FLUOROPYRIMIDINES: ACUTE ESOPHAGEAL NECROSIS ASSOCIATED EXTENSIVE DUODENAL MUCOSITIS. Revista Española de Enfermedades Digestivas. 5 indexed citations
11.
Carmona‐Bayonas, Alberto, David Gómez, Eva Martínez de Castro, et al.. (2020). A snapshot of cancer-associated thromboembolic disease in 2018–2019: First data from the TESEO prospective registry. European Journal of Internal Medicine. 78. 41–49. 25 indexed citations
12.
Carmona‐Bayonas, Alberto, Rocio García‐Carbonero, Ana Custodio, et al.. (2019). Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study). British Journal of Cancer. 121(7). 537–544. 24 indexed citations
13.
Fernández, Ana, et al.. (2019). Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables. Scientific Reports. 9(1). 16979–16979. 25 indexed citations
14.
Montés, Ana Fernández, Carlos López, David Gutiérrez Abad, et al.. (2019). Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis. The Oncologist. 24(8). e687–e695. 20 indexed citations
15.
García-Martínez, Elena, Melody Smith, Aitziber Buqué, et al.. (2018). Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. OncoImmunology. 7(6). e1433982–e1433982. 39 indexed citations
16.
Carrillo, Andrés, et al.. (2018). Long-term survival and performance status of cancer patients after discharge from ICU (intensive care unit).. Journal of Clinical Oncology. 36(15_suppl). e18744–e18744. 1 indexed citations
17.
Sánchez‐Lorenzo, Luisa, et al.. (2017). CP-075 Prognostic factors in patients with recurrent epithelial ovarian cancer. A33.2–A33. 1 indexed citations
18.
Carmona‐Bayonas, Alberto, et al.. (2017). The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score. Clinical & Translational Oncology. 19(9). 1084–1090. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas Cloarec Breakdown of academic impact, for papers by Adam Zayac Breakdown of academic impact, for papers by Yana Novis Breakdown of academic impact, for papers by Priya Sriskandarajah Breakdown of academic impact, for papers by Syed A. Abutalib Breakdown of academic impact, for papers by Roald Lindås Breakdown of academic impact, for papers by Ajay Sharma Breakdown of academic impact, for papers by J J Viala Breakdown of academic impact, for papers by Bao‐Wen Tian Breakdown of academic impact, for papers by Sandra Rutzner
Rankless by CCL
2026